A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Clinical trial NCT02655614 · COMPLETED
Trial details
- NCT number
- NCT02655614
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2020-03-16
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.